Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-β-dependent mechanism

Journal of Immunology

Volumn 177, Issue 10, 2006, Pages 7164-7172

  Kato, Atsushi ^a   Truong Tran, Ai Q ^a   Scott, Alan L ^b   Matsumoto, Kenji ^c   Schleimer, Robert P ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; APRIL PROTEIN; BETA INTERFERON; BETA INTERFERON RECEPTOR; CYCLOHEXIMIDE; CYTOKINE; DOUBLE STRANDED RNA; IMMUNOGLOBULIN CLASS; JANUS KINASE; JANUS KINASE INHIBITOR; MESSENGER RNA; PROTEIN BAFF; SMALL INTERFERING RNA; STAT PROTEIN; STAT1 PROTEIN; TOLL LIKE RECEPTOR 3; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

AIRWAY; ARTICLE; AUTOCRINE EFFECT; B LYMPHOCYTE; CELL ACTIVATION; CELL ASSAY; CELL STRAIN; CELL SURVIVAL; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOGLOBULIN AGGREGATE; IMMUNOGLOBULIN PRODUCTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT MUCOSA; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 33750833354     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.10.7164     Document Type: Article

References (69)

1. Hogg, J. C., and P. A. Eggleston. 1984. Is asthma an epithelial disease? Am. Rev. Respir. Dis. 129: 207-208.
2. Cohn, L. A., and K. B. Adler. 1992. Interactions between airway epithelium and mediators of inflammation. Exp. Lung Res. 18: 299-322.
3. Rennard, S. I., D. J. Romberger, J. H. Sisson, S. G. Von Essen, I. Rubinstein, R. A. Robbins, and J. R. Spurzem. 1994. Airway epithelial cells: functional roles in airway disease. Am. J. Respir. Crit. Care Med. 150: S27-S30.
4. Abreu, M. T., M. Fukata, and M. Arditi. 2005. TLR signaling in the gut in health and disease. J. Immunol. 174: 4453-4460.
5. Diamond, G., D. Legarda, and L. K. Ryan. 2000. The innate immune response of the respiratory epithelium. Immunol. Rev. 173: 27-38.
6. Sha, Q., A. Q. Truong-Tran, J. R. Plitt, L. A. Beck, and R. P. Schleimer. 2004. Activation of airway epithelial cells by Toll-like receptor agonists. Am. J. Respir. Cell Mol. Biol. 31: 358-364.
7. Mills, P. R., R. J. Davies, and J. L. Devalia. 1999. Airway epithelial cells, cytokines, and pollutants. Am. J. Respir. Crit. Care Med. 160: S38-S43.
8. Polito, A. J., and D. Proud. 1998. Epithelia cells as regulators of airway inflammation. J. Allergy Clin. Immunol. 102: 714-718.
9. Diaz-Sanchez, D., A. R. Dotson, H. Takenaka, and A. Saxon. 1994. Diesel exhaust particles induce local IgE production in vivo and alter the pattern of IgE messenger RNA isoforms. J. Clin. Invest. 94: 1417-1425.
10. Ying, S., M. Humbert, Q. Meng, R. Pfister, G. Menz, H. J. Gould, A. B. Kay, and S. R. Durham. 2001. Local expression of ε germline gene transcripts and RNA for the ε heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma. J. Allergy Clin. Immunol. 107: 686-692.
11. Takhar, P., L. Smurthwaite, H. A. Coker, D. J. Fear, G. K. Banfield, V. A. Carr, S. R. Durham, and H. J. Gould. 2005. Allergen drives class switching to IgE in the nasal mucosa in allergic rhinitis. J. Immunol. 174: 5024-5032.
12. Gauchat, J. F., J. P. Aubry, G. Mazzei, P. Life, T. Jomotte, G. Elson, and J. Y. Bonnefoy. 1993. Human CD40-ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production. FEBS Lett. 315: 259-266.
13. Quezada, S. A., L. Z. Jarvinen, E. F. Lind, and R. J. Noelle. 2004. CD40/CD154 interactions at the interface of tolerance and immunity. Annu. Rev. Immunol. 22: 307-328.
14. Fagarasan, S., and T. Honjo. 2000. T-Independent immune response: new aspects of B cell biology. Science 290: 89-92.
15. Litinskiy, M. B., B. Nardelli, D. M. Hilbert, B. He, A. Schaffer, P. Casali, and A. Cerutti. 2002. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol. 3: 822-829.
16. Fagarasan, S., and T. Honjo. 2003. Intestinal IgA synthesis: regulation of frontline body defenses. Nat. Rev. Immunol. 3: 63-72.
17. Hangartner, L., R. M. Zinkernagel, and H. Hengartner. 2006. Antiviral antibody responses: the two extremes of a wide spectrum. Nat. Rev. Immunol. 6: 231-243.
18. Hahne, M., T. Kataoka, M. Schroter, K. Hofmann, M. Irmler, J. L. Bodmer, P. Schneider, T. Bornand, N. Holler, L. E. French, et al. 1998. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J. Exp. Med. 188: 1185-1190.
19. Moore, P. A., O. Belvedere, A. Orr, K. Pieri, D. W. LaFleur, P. Feng, D. Soppet, M. Charters, R. Gentz, D. Parmelee, et al. 1999. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285: 260-263.
20. Schneider, P., F. MacKay, V. Steiner, K. Hofmann, J. L. Bodmer, N. Holler, C. Ambrose, P. Lawton, S. Bixler, H. Acha-Orbea, el al. 1999. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189: 1747-1756.
21. Mackay, F., P. Schneider, P. Rennert, and J. Browning. 2003. BAFF and APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 21: 231-264.
22. Ng, L. G., C. R. Mackay, and F. Mackay. 2005. The BAFF/APRIL system: life beyond B lymphocytes. Mol. Immunol. 42: 763-772.
23. Schneider, P. 2005. The role of APRIL and BAFF in lymphocyte activation. Curr. Opin. Immunol. 17: 282-289.
24. Castigli, E., S. A. Wilson, S. Scott, F. Dedeoglu, S. Xu, K. P. Lam, R. J. Bram, H. Jabara, and R. S. Geha. 2005. TACI and BAFF-R mediate isotype switching in B cells. J. Exp. Med. 201: 35-39.
25. Lentz, V. M., M. P. Cancro, F. E. Nashold, and C. E. Hayes. 1996. Bcmd governs recruitment of new B cells into the stable peripheral B cell pool in the A/WySnJ mouse. J. Immunol. 157: 598-606.
26. Sasaki, Y., S. Casola, J. L. Kutok, K. Rajewsky, and M. Schmidt-Supprian. 2004. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J. Immunol. 173: 2245-2252.
27. Mariette, X., S. Roux, J. Zhang, D. Bengoufa, F. Lavie, T. Zhou, and R. Kimberly. 2003. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome. Ann. Rheum. Dis. 62: 168-171.
28. Baker, K. P., B. M. Edwards, S. H. Main, G. H. Choi, R. E. Wager, W. G. Halpern, P. B. Lappin, T. Riccobene, D. Abramian, L. Sekut, et al. 2003. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Arthritis Rheum. 48: 3253-3265.
29. Mackay, F., S. A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, P. Schneider, J. Tschopp, and J. L. Browning. 1999. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190: 1697-1710.
30. Salzer, U., H. M. Chapel, A. D. Webster, Q. Pan-Hammarstrom, A. Schmitt-Graeff, M. Schlesien, H. H. Peter, J. K. Rockstroh, P. Schneider, A. A. Schaffer, et al. 2005. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat. Genet. 37: 820-828.
31. Becker, M. N., G. Diamond, M. W. Verghese, and S. H. Randell. 2000. CD14-dependent lipopolysaccharide-induced β-defensin-2 expression in human tracheobronchial epithelium. J. Biol. Chem. 275: 29731-29736.
32. Shuto, T., A. Imasato, H. Jono, A. Sakai, H. Xu, T. Watanabe, D. D. Rixter, H. Kai, A. Andalibi, F. Linthicum, et al. 2002. Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-mduced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J. Biol. Chem. 277: 17263-17270.
33. Schulz, C., L. Farkas, K. Wolf, K. Kratzel, G. Eissner, and M. Pfeifer. 2002. Differences in LPS-induced activation of bronchial epithelial cells (BEAS-2B) and type II-like pneumocytes (A-549). Scand. J. Immunol. 56: 294-302.
34. Homma, T., A. Kato, N. Hashimoto, J. Batchelor, M. Yoshikawa, S. Imai, H. Wakiguchi, H. Saito, and K. Matsumoto. 2004. Corticosteroid and cytokines synergistically enhance Toll-like receptor 2 expression in respiratory epithelial cells. Am. J. Respir. Cell Mol. Biol. 31: 463-469.
35. Reddel, R. R., Y. Ke, B. I. Gerwin, M. G. McMenamin, J. F. Lechner, R. T. Su, D. E. Brash, J. B. Park, J. S. Rhim, and C. C. Harris. 1988. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res. 48: 1904-1909.
36. Atsuta, J., J. Plitt, B. S. Bochner, and R. P. Schleimer. 1999. Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids. Am. J. Respir. Cell Mol. Biol. 20: 643-650.
37. Kato, A., T. Ogasawara, T. Homma, H. Saito, and K. Matsumoto. 2004. Lipopolysaccharide-binding protein critically regulates lipopolysaccharide- induced I1FN-β signaling pathway in human monocytes. J. Immunol. 172: 6185-6194.
38. Kato, A., T. Homma, J. Batchelor, N. Hashimoto, S. Imai, H. Wakiguchi, H. Saito, and K. Matsumoto. 2003. Interferon-αβ receptor-mediated selective induction of a gene cluster by CpG oligodeoxynucleotide 2006. BMC Immunol. 4: 8.
39. Gavin, A. L., D. Ait-Azzouzene, C. F. Ware, and D. Nemazee. 2003. δBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF. J. Biol. Chem. 278: 38220-38228.
40. Gavin, A. L., B. Duong, P. Skog, D. Ait-Azzouzene, D. R. Greaves, M. L. Scott, and D. Nemazee. 2005. δBAFF, a splice isoform of BAFF, opposes full-length BAFF activity in vivo in transgenic mouse models. J. Immunol. 175: 319-328.
41. Nardelli, B., O. Belvedere, V. Roschke, P. A. Moore, H. S. Olsen, T. S. Migone, S. Sosnovtseva, J. A. Carrell, P. Feng, J. G. Giri, and D. M. Hilbert. 2001. Synthesis and release of B-lymphocyte stimulator from myeloid cells. Blood 97: 198-204.
42. Scapini, P., B. Nardelli, G. Nadali, F. Calzetti, G. Pizzolo, C. Montecucco, and M. A. Cassatella. 2003. G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J. Exp. Med. 197: 297-302.
43. Nishio, M., T. Endo, N. Tsukada, J. Ohata, S. Kitada, J. C. Reed, N. J. Zvaifler, and T. J. Kipps. 2005. Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1α. Blood 106: 1012-1020.
44. Krumbholz, M., D. Theil, T. Derfuss, A. Rosenwald, F. Schrader, C. M. Monoranu, S. L. Kalled, D. M. Hess, B. Serafini, F. Aloisi, et al. 2005. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J. Exp. Med. 201: 195-200.
45. Ittah, M., C. Miceli-Richard, J. Eric Gottenberg, F. Lavie, T. Lazure, N. Ba, J. Sellam, C. Lepajolec, and X. Mariette. 2006. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome. Arthritis Res. Ther. 8: R51.
46. Ronni, T., S. Matikainen, T. Sareneva, K. Melen, J. Pirhonen, P. Keskinen, and I. Julkunen. 1997. Regulation of IFN-αβ, MxA, 2′,5′-oligoadenylate synthetase, and HLA gene expression in influenza A-infected human lung epithelial cells. J. Immunol. 158: 2363-2374.
47. Guillot, L., R. Le Goffic, S. Bloch, N. Escriou, S. Akira, M. Chignard, and M. Si-Tahar. 2005. Involvement of Toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 280: 5571-5580.
48. Thompson, J. E., R. M. Cubbon, R. T. Cummings, L. S. Wicker, R. Frankshun, B. R. Cunningham, P. M. Cameron, P. T. Meinke, N. Liverton, Y. Weng, and J. A. DeMartino. 2002. Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor. Bioorg. Med. Chem. Lett. 12: 1219-1223.
49. Tliba, O., R. A. Panettieri, Jr., S. Tliba, T. F. Walseth, and Y. Amrani. 2004. Tumor necrosis factor-α differentially regulates the expression of proinflammatory genes in human airway smooth muscle cells by activation of interferon-β-dependent CD38 pathway. Mol. Pharmacol. 66: 322-329.
50. Schleimer, R. P. 2003. Glucocorticoids: Part A: Mechanisms of action in allergic diseases. In Middleton's Allergy: Principles and Practice. J. W. Yunginger, N. F. Adkinson, Jr., W. W. Busse, B. S. Bochner, S. T. Holgate, and F. E. R. Simons, eds. Mosby, St. Louis, pp. 870-913.
51. Pugin, J., C. C. Schurer-Maly, D. Leturcq, A. Moriarty, R. J. Ulevitch, and P. S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90: 2744-2748.
52. Doyle, S., S. Vaidya, R. O'Connell, H. Dadgostar, P. Dempsey, T. Wu, G. Rao, R. Sun, M. Haberland, R. Modlin, and G. Cheng. 2002. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17: 251-263.
53. Moynagh, P. N. 2005. TLR signaling and activation of IRFs: revisiting old friends from the NF-κB pathway. Trends Immunol. 26: 469-476.
54. Jefferies, C. A., and K. A. Fitzgerald. 2005. Interferon gene regulation: not all roads lead to Tolls. Trends Mol. Med. 11: 403-411.
55. Platanias, L. C. 2005. Mechanisms of type-I- and type-II-interferon- mediated signaling. Nat. Rev. Immunol. 5: 375-386.
56. Decker, T., M. Muller, and S. Stockinger. 2005. The yin and yang of type I interferon activity in bacterial infection. Nat. Rev. Immunol. 5: 675-687.
57. Naclerio, R. M., N. F. Adkinson, Jr., B. Moylan, F. M. Baroody, D. Proud, A. Kagey-Sobotka, L. M. Lichtenstein, and R. Hamilton. 1997. Nasal provocation with allergen induces a secondary serum IgE antibody response. J. Allergy Clin. Immunol. 100: 505-510.
58. Naclerio, R. M., N. F. Adkinson, Jr., P. S. Creticos, F. M. Baroody, R. G. Hamilton, and P. S. Norman. 1993. Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies. J. Allergy Clin. Immunol. 92: 717-721.
59. Avila, P. C. 2000. Interactions between allergic inflammation and respiratory viral infections. J. Allergy Clin. Immunol 106: 829-831.
60. Johnston, S. L. 2005. Overview of virus-induced airway disease. Proc. Am. Thorac. Soc. 2: 150-156.
61. Contoli, M., G. Caramori, P. Mallia, S. Johnston, and A. Papi. 2005. Mechanisms of respiratory virus-induced asthma exacerbations. Clin. Exp. Allergy 35: 137-145.
62. Coker, H. A., S. R. Durham, and H. J. Gould. 2003. Local somatic hypermutation and class switch recombination in the nasal mucosa of allergic rhinitis patients. J. Immunol. 171: 5602-5610.
63. Cameron, L., Q. Hamid, E. Wright, Y. Nakamura, P. Christodoulopoulos, S. Muro, S. Frenkiel, F. Lavigne, S. Durham, and H. Gould. 2000. Local synthesis of ε germline gene transcripts, IL-4, and IL-13 in allergic nasal mucosa after ex vivo allergen exposure. J. Allergy Clin. Immunol. 106: 46-52.
64. KleinJan, A., J. G. Vinke, L. W. Severijnen, and W. J. Fokkens. 2000. Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur. Respir. J. 15: 491-497.
65. Nakajima, S., D. N. Gillespie, and G. J. Gleich. 1975. Differences between IgA and IgE as secretory proteins. Clin. Exp. Immunol. 21: 306-317.
66. Merrett, T. G., M. Houri, A. L. Mayer, and J. Merrett. 1976. Measurement of specific IgE antibodies in nasal secretion: evidence for local production. Clin. Allergy 6: 69-73.
67. Small, P., D. Barrett, S. Frenkiel, L. Rochon, C. Cohen, and M. Black. 1985. Local specific IgE production in nasal polyps associated with negative skin tests and serum RAST. Ann. Allergy 55: 736-739.
68. Schleimer, R. P. 2004. Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc. Am. Thorac. Soc. 1: 222-230.
69. Sutherland, A. P., L. G. Ng, C. A. Fletcher, B. Shum, R. A. Newton, S. T. Grey, M. S. Rolph, F. Mackay, and C. R. Mackay. 2005. BAFF augments certain Th1-associated inflammatory responses. J. Immunol. 174: 5537-5544.